Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients
Clinical trial NCT03127020 · COMPLETED
Trial details
- NCT number
- NCT03127020
- Sponsor
- PIQUR Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2019-03-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.